LYSTEDA
Live / Registered — Registered and renewed (as of 23 Oct 2020)
What this means for you
Registered since 15 Mar 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 15 Mar 2021).
Record
- Serial number
- 77560854
- Registration number
- 3931482
- Mark type
- Stylized text
- Filed
- 02 Sept 2008
- Published for opposition
- 20 Jan 2009
- Registered
- 15 Mar 2011
- Next maintenance due
- 15 Mar 2021
- Attorney of record
- Anna Kurian Shaw
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of menorrhagia
Owner
- NORDIC PHARMA, INC., BERWYN, PA, US
- AMRING PHARMACEUTICALS INC., BERWYN, PA, US
- Ferring B.V., Hoofddorp, NL
- Ferring B.V., 2132 JX Hoofddorp, NL
- Xanodyne Pharmaceuticals, Inc., Newport, KY, US
- Xanodyne Pharmaceuticals, Inc., Newport, KY, US
Prosecution history
- 17 Apr 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 04 Apr 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Apr 2024 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 04 Apr 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Apr 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Apr 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 04 Apr 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 09 Jun 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 23 Oct 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 23 Oct 2020 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 23 Oct 2020 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 23 Oct 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Sept 2020 — TEAS SECTION 8 & 9 RECEIVED
- 15 Mar 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 04 May 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED